The Home HBOT Resource Center

Wound healing, cognitive function, athletic recovery, and anti-aging telomere research — plus how home sessions compare to clinical HBOT.

Home soft-shell from $3,000–$10,000. Clinical units at $100K+. The full breakdown — plus whether buying beats renting or clinic sessions once you run the numbers.

20–40 sessions for most conditions. Exact protocols by goal — wound healing, cognitive, athletic recovery, anti-aging — plus session frequency and when to expect results.

Top 5 home chambers ranked by pressure, price, and build quality. Soft-shell vs. hard-shell decision guide and buying checklist for first-time buyers.

Side effects table, who shouldn't use HBOT, soft-shell vs. hard-shell safety comparison, and a practical 7-point home chamber checklist.

How elite athletes (LeBron, Ronaldo, NFL teams) use HBOT to recover faster and train harder — the science, protocols, and home vs. clinical comparison for serious athletes.

The Tel Aviv telomere study, senescent cell clearance, stem cell mobilization — the longevity science behind HBOT and protocols used by biohackers and longevity clinics.

TBI, stroke, concussion, brain fog — how HBOT drives neuroplasticity, reduces neuroinflammation, and supports recovery. Evidence from Dr. Paul Harch, Dr. Shai Efrati, and the long COVID RCT.

How HBOT suppresses TNF-α and IL-6 — with clinical evidence for fibromyalgia, rheumatoid arthritis, CRPS, and post-surgical pain, plus home chamber protocols for ongoing management.

FDA-cleared for diabetic foot ulcers, radiation injury, and crush injuries — HBOT's strongest evidence base. Löndahl 2010, Faglia 1996, and the amputation prevention data explained.

The Zilberman-Itskovich 2022 RCT: 73 patients, 40 sessions at 2.0 ATA — significant improvements in brain fog, fatigue, sleep, and pain, with MRI perfusion data confirming the effect.

Central sensitization, neuroinflammation, and mitochondrial dysfunction — the three mechanisms driving FM/CFS that HBOT addresses. Yildiz 2004 and Efrati 2015 RCT evidence with fMRI confirmation.

Borrelia burgdorferi is microaerophilic — it thrives where oxygen is scarce. HBOT floods tissues with oxygen it cannot tolerate, disrupts protective biofilms, and reduces the neuroinflammation driving chronic Lyme and PTLDS symptoms.